The purpose of this study is to evaluate the intermediate to long-term clinical and radiographic outcomes of posterior talar OCD*s treated by means of 2-portal hindfoot approach.
ID
Source
Brief title
Condition
- Joint disorders
- Bone and joint therapeutic procedures
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
The goal of this study is to evaluate the treatment. The primary outcome
measure is the subjective outcome of the patients, measured by the Berndt &
Harty Outcome score, and the Ogilvie-Harris score.
Secondary outcome
Secondary outcome measures are the VAS pain score at rest, during walking, and
during running, the AOFAS score, the SF-36, the Berndt & Harty classification
of osteochondral defects of the talus and the osteoarthritis classification
previously published by Van Dijk et al.
Background summary
The natural course of degenerative joint disease following an osteochondral
defect(OCD) has not been well defined, although subchondral cysts may form and
osteoarthritis could be a long term sequel. Arthroscopic debridement and bone
marrow stimulation is considered the gold standard for treatment of primary
talar OCD*s with good or excellent results. However, to our knowledge, there
are no reports about the outcome of treatment of OCD*s of the talus by means of
2-portal hindfoot approach. Our hypothesis is that the initial success of
posterior arthroscopic treatment for posterior located OCD*s of the talus is
maintained over time and that patients are overall still satisfied with the
results, with no significant changes in osteoarthritic grading, after at least
10 years of follow-up.
Study objective
The purpose of this study is to evaluate the intermediate to long-term clinical
and radiographic outcomes of posterior talar OCD*s treated by means of
2-portal hindfoot approach.
Study design
Therapeutic retrospective study.
Study burden and risks
Patients will receive one outpatient assessment including two radiographs of
their operated ankle.
Meibergdreef 9 Meibergdreef 9
Amsterdam 1105 AZ
NL
Meibergdreef 9 Meibergdreef 9
Amsterdam 1105 AZ
NL
Listed location countries
Age
Inclusion criteria
- Patients that were treated for an osteochondral defect of the talus by means of 2-portal hindfoot approach in the AMC from 1988 until 2012
- Capable of filling out a questionnaire
- Signed informed consent
Exclusion criteria
- Systemic disease (e.g. rheumatoid arthritis, lupus erythematosus)
- Ankle trauma 6 months or less prior to follow-up
- Painful or invalid disorder of the lower extremity
- Inability to understand the patient information and the questionnaires (e.g. mental retardation, language barrier)
- No informed consent
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| CCMO | NL55550.018.15 |